Class II Invariant Chain HCV Vaccine Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The study is aimed at assessing the safety and immunogenicity of HCV prime-boost vaccinations ChAd3-hliNSmut and MVA-hliNSmut, administered intramuscularly in healthy volunteers and DAA treated patients.
Epistemonikos ID: fbaad5665d179f816c8db271083b6da9fae51bf5
First added on: May 21, 2024